Last Price
0.806
Today's Change
-0.033 (3.93%)
Day's Change
0.789 - 0.869
Trading Volume
31,314,498
Profile
DNA
Exchange: New York Stock Exchange New York Stock Exchange
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Jason Kelly Dr. Jason Kelly
Full Time Employees: 1,218 1,218
IPO Date: 2021-04-19 2021-04-19
CIK: 0001830214 0001830214
ISIN: US37611X1000 US37611X1000
CUSIP: 37611X100 37611X100
Beta: 1.42 1.42
Last Dividend: 0.00 0.00
Dcf Diff: 0.00 0.00
Dcf: 0.00 0.00
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
US Federal Court Enforces SEC's Subpoena to Depose Elon Musk
2
CEO Morning Brief
3
4
CEO Morning Brief
US Core CPI Cools for First Time in Six Months in Relief for Fed
5
CEO Morning Brief
Visa Adds New Way to Share Customer Shopping Data With Retailers
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
